AVBP · ArriVent BioPharma, Inc.
$28.22
-4.97 (-14.97%)
At close · Jul 20
Market Cap
$1.32B
Shares
46.57M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-02-03 | $250,000,000 | — | — | — | 8-K , filed 2026-05-11 |
Key facts
CIK
1868279
CUSIP
04272N102
13F (30d)
11 filings
11 filers
Visit website
Investor relations